Jove
Visualize
お問い合わせ

関連する概念動画

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

72
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
72
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

91
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
91
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  3. 血糖/リンパ球比と,糖尿病のない心筋梗塞の患者におけるコントラスト誘発性急性腎臓損傷との関連
  1. ホーム
  3. 血糖/リンパ球比と,糖尿病のない心筋梗塞の患者におけるコントラスト誘発性急性腎臓損傷との関連

関連する実験動画

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

512

血糖/リンパ球比と,糖尿病のない心筋梗塞の患者におけるコントラスト誘発性急性腎臓損傷との関連

Murat Gök1, Alparslan Kurtul2, Orçun Demir1

  • 1Trakya University Faculty of Medicine, Edirne - Turquia.

Arquivos brasileiros de cardiologia
|August 20, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

高血糖対リンパ球比 (GLR) は,ST上昇心筋梗塞 (STEMI) の患者における一次性皮経冠動脈干渉 (PPCI) の後のコントラスト誘発性急性腎臓損傷 (CI- AKI) の重要な独立リスク因子である. この発見は,この集団におけるCI- AKIの潜在的予測マーカーとしてGLRを強調しています.

さらに関連する動画

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.6K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.4K

関連する実験動画

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

512
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.6K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.4K

科学分野:

  • 心臓病科
  • 腎臓科
  • 臨床生化学

背景:

  • グルコース代謝と全身の炎症は,心血管疾患と関連しています.
  • リンパ球に対するグルコース比 (GLR) は,がんの予後のための新しいマーカーです.
  • GLRと心血管疾患,特にCI-AKIの関連性は未調査のままである.

研究 の 目的:

  • GLRとコントラスト誘発性急性腎損傷 (CI-AKI) のリスクとの関連を調査する.
  • 主要経皮冠動脈干渉 (PPCI) を受けているST上昇急性心筋梗塞 (STEMI) 患者のCI- AKIの予測マーカーとしてGLRを評価する.

主な方法:

  • PPCIを受けた592人の非糖尿病性STEMI患者の臨床データを遡及分析した.
  • 末期腎疾患,欠落したデータ,がん,または炎症性/感染症の患者を除外する.
  • 高GLR (≥4.16) と低GLR (<4.16) のグループに分類するROC曲線解析を用いて最適なGLRカットオフの決定.

主要な成果:

  • CI- AKIの総発生率は7. 4%でした.
  • 高GLR群の患者は,低GLR群と比較してCI- AKIの発生率 (30. 9%) が著しく高かった (1. 3%,p< 0. 001).
  • 高GLRはCI- AKI (OR 45. 100,p< 0. 001) の独立予測因子として,投与中のクレアチニン (OR 10. 459,p=0. 036) とともに特定された.

    • 結論:

    • 糖尿病のないSTEMI患者におけるPPCI後のCI- AKI発症の独立リスク因子である.
    • GLRは,この特定の患者コホートにおけるCI- AKIの貴重な予測バイオマーカーとして機能する.